| (S)-4-(TERT-BUTOXY)-2-ISOPROPYL-4-OXOBUTANOIC ACID |
(S)-4-叔丁氧-2-异丙基-4-氧丁酸 |
134807-43-5 |
| Levosimendan Impurity 10 |
Levosimendan Impurity 10 |
134678-47-0 |
| 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
西地那非杂质9 |
139756-31-3 |
| 2,5-Piperazinedione,3-phenyl-,(3S)-(9CI) |
(3S)-3-苯基哌嗪-2,5二酮 |
134521-82-7 |
| 5β-Finasteride |
非那雄胺杂质D |
140375-22-0 |
| (3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride |
LURASIDONE ISOMER (S,S-EXO) |
139563-18-1 |
| Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate |
坎地沙坦酯中间体 |
139481-41-7 |
| Azilsartan iMpurity I |
阿齐沙坦杂质I |
139481-33-7 |
| Ethyl -2-ethoxy-1-[[(2-(1Htetrazol-5-yl)biphenyl-4-yl-) methyl] |
坎地沙坦乙酯 |
139481-58-6 |
| Candesartan |
坎地沙坦 |
139481-59-7 |
| (S)-4-(4-Nitrobenzyl)-2-oxazolidinone |
(S)-4-[(4-硝基苯基)甲基]-2-恶唑烷酮 |
139264-55-4 |
| Didesmethyl Zolmitriptan |
佐米曲坦双去甲基杂质 |
139264-15-6 |
| Zolmitriptan |
佐米曲坦R异构体 |
139264-24-7 |
| N-DESMETHYL ZOLMITRIPTAN HCL |
N-去甲佐米曲坦-D3 |
139264-35-0 |
| Irbesartan Impurity 14 |
Irbesartan Impurity 14 |
133690-91-2 |
| Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)- |
布南色林杂质C |
132811-84-8 |
| Valsartan cyano analog methyl ester |
缬沙坦氰基类似物甲基酯 |
137863-90-2 |
| Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
布南色林杂质2 |
132810-75-4 |
| Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- |
布南色林杂质17 |
132813-13-9 |
| Blonanserin iMpurity |
布南色林杂质 |
132810-83-4 |
QQ
微信
